DILATE Study
Post-aSAH Cerebral Vasospasm
Clinical TrialActive
Key Facts
About Vesalio
Vesalio is a private, commercial-stage medical device company developing novel thrombectomy technologies for acute vascular occlusions across multiple territories, including stroke, heart attack, and peripheral arterial disease. Its core innovation is the patented Drop Zone technology, designed to improve first-pass success and clot retention. The company has achieved significant regulatory milestones, including FDA clearance and CE Mark for its flagship products, positioning it in large, high-need cardiovascular markets.
View full company profile